Targeted Cancer Treatment (Theranostics)
The future of cancer care. "Theranostics" means we use one radioactive drug to find the cancer, and a second, specialized drug to treat it directly.
Pluvicto (Lu-177 PSMA): Precision targeted therapy for advanced prostate cancer.
Lutathera (Lu-177 DOTATATE): Targeted therapy for neuroendocrine tumors.
Radioactive Iodine (I-131): Safe and proven treatment for hyperthyroidism and certain thyroid cancers.
Things to Know: Before, During and After Treatment.
Your care team will explain whether targeted treatment may be appropriate for you and what your visits would involve. Contact us to discuss a referral or request a consultation.
Before your visit
Bring your referring physician’s order, insurance card, and photo identification. Ask our team which records and scan results are needed for your consultation.
A plan for your care
Preparation, visit length, and instructions after treatment depend on the therapy. Follow the specific instructions provided by your care team and ask about any questions or concerns.